Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_assertion description "[In this study, we evaluated the ability of ATN-161 (Ac-PHSCN-NH2), a 5-mer capped peptide derived from the synergy region of fibronectin that binds to alpha5beta1 and alphavbeta3 in vitro, to block breast cancer growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_assertion evidence source_evidence_literature NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_assertion SIO_000772 16985061 NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_assertion wasDerivedFrom befree-2016 NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_assertion wasGeneratedBy ECO_0000203 NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.
- befree-2016 importedOn "2016-02-19" NP570190.RAWnX_Gp8p1XLNSHZgaoHEQ02FHob2YCi1oLd0IlKgVtg130_provenance.